Myovant Sciences Ltd.
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Myovant Sciences Ltd. generated cash of -$268,559,000, which is less than the previous year. Cash used in financing activities reached the amount of $25,905,000 last year. Net change in cash is therefore -$260,676,000.
Cash Flow
| 2017 | -18.21M | -967K | 200.02M |
|---|---|---|---|
| 2018 | -117.25M | -604K | 45.64M |
| 2019 | -224.08M | -1.23M | 273.89M |
| 2020 | -221.17M | -3.93M | 145.92M |
| 2021 | 370.62M | -9.21M | 238.04M |
| 2022 | -268.55M | -18.02M | 25.90M |
MYOV Cash Flow Statement (2017 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|
Cash at beginning of period | 677.48M | 78.01M | 157.19M | 108.62M | 180.83M | 0 |
Operating activities | ||||||
Net income | -205.98M | -255.13M | -288.98M | -273.55M | -143.25M | -83.44M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||
Depreciation and amortization | 3.07M | 2.47M | 1.76M | 438K | 243K | 61K |
Stock-based compensation expense | 38.92M | 53.67M | 40.25M | 18.69M | 11.58M | 8.71M |
| Deferred income tax benefit | 38.92M | 53.67M | 40.25M | 18.69M | 11.58M | 8.71M |
| Changes in operating assets and liabilities: | ||||||
Accounts receivable, net | -19.72M | -3.57M | 0 | 0 | 0 | 0 |
Inventories | -4.97M | -2.61M | 0 | 0 | 0 | 0 |
Accounts payable | -5.61M | 2.45M | 4.31M | 6.44M | 1.24M | 3.32M |
Cash generated by operating activities | -268.55M | 370.62M | -221.17M | -224.08M | -117.25M | -18.21M |
Investing activities | ||||||
Purchases Of Investments | -118.74M | -63.82M | -32.07M | 0 | 0 | 0 |
Investments In Property Plant And Equipment | -974K | -1.77M | -1.09M | -1.23M | -604K | -967K |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 |
Cash generated by investing activities | -18.02M | -9.21M | -3.93M | -1.23M | -604K | -967K |
Financing activities | ||||||
Common Stock Issued | 0 | 0 | 137.00M | 218.92M | 1.85M | 202.27M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | -105.42M | 0 | 0 | 0 |
Cash used in financing activities | 25.90M | 238.04M | 145.92M | 273.89M | 45.64M | 200.02M |
Net Change In Cash | -260.67M | 599.46M | -79.18M | 48.57M | -72.21M | 180.83M |
Cash at end of period | 416.80M | 677.48M | 78.01M | 157.19M | 108.62M | 180.83M |
| Data source | Data source | Data source | Data source | Data source | Data source |